Neuregulin-1 signalling and antipsychotic treatment

No abstract is available for this paper.

• Publication year

  2013

• Venue

  Psychopharmacology

• Publication date

  2013-02-07

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1007/s00213-013-3003-2PMID 23389757
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Decreased peripheral expression of neuregulin 1 in high-risk individuals who later converted to psychosis.

  2012cited by this paper
• Cognition in female transmembrane domain neuregulin 1 mutant mice.

  2012cited by this paper
• The Importance of the NRG-1/ErbB4 Pathway for Synaptic Plasticity and Behaviors Associated with Psychiatric Disorders

  2012cited by this paper
• Genetic associations between neuregulin-1 SNPs and neurocognitive function in multigenerational, multiplex schizophrenia families

  2012cited by this paper
• Association study of neuregulin 1 gene polymorphisms with auditory p300 in schizophrenia

  2012cited by this paper
• Association Analysis of 94 Candidate Genes and Schizophrenia-Related Endophenotypes

  2012cited by this paper
• [Expressional changes of neuregulin-1 gene mRNA in peripheral blood from schizophrenia patients].

  2011cited by this paper
• Neuregulin 1 Promotes Excitatory Synapse Development and Function in GABAergic Interneurons

  2011cited by this paper
• Systemic administration of neuregulin‐1β1 protects dopaminergic neurons in a mouse model of Parkinson’s disease

  2011cited by this paper
• No NRG1 V266L in Chinese patients with schizophrenia

  2011cited by this paper
• Dysbindin-1 and NRG-1 gene expression in immortalized lymphocytes from patients with schizophrenia

  2011cited by this paper
• Schizophrenia susceptibility pathway neuregulin 1–ErbB4 suppresses Src upregulation of NMDA receptors

  2011cited by this paper
• Subchronic Peripheral Neuregulin-1 Increases Ventral Hippocampal Neurogenesis and Induces Antidepressant-Like Effects

  2011cited by this paper
• The role of serotonin receptors in the action of atypical antipsychotic drugs.

  2011cited by this paper
• ErbB4 localization to interneurons: clearer insights into schizophrenia pathology.

  2011cited by this paper
• Neuroplasticity signaling pathways linked to the pathophysiology of schizophrenia.

  2011cited by this paper
• Specific Regulation of NRG1 Isoform Expression by Neuronal Activity

  2011cited by this paper
• Sex-specific neuroendocrine and behavioral phenotypes in hypomorphic Type II Neuregulin 1 rats.

  2011cited by this paper
• The influence of schizophrenia-related neuregulin-1 polymorphisms on sensorimotor gating in healthy males.

  2011cited by this paper
• Disrupted Activity in the Hippocampal–Accumbens Circuit of Type III Neuregulin 1 Mutant Mice

  2011cited by this paper
• Neuregulin signaling, cortical circuitry development and schizophrenia.

  2011cited by this paper
• Parenteral administration of recombinant human neuregulin‐1 to patients with stable chronic heart failure produces favourable acute and chronic haemodynamic responses

  2011cited by this paper
• Conserved interneuron-specific ErbB4 expression in frontal cortex of rodents, monkeys, and humans: implications for schizophrenia.

  2011cited by this paper
• Differential localization of neuregulin-1 type III in the central and peripheral nervous system

  2011cited by this paper
• Reciprocal signalling between NR2 subunits of the NMDA receptor and neuregulin1 and their role in schizophrenia.

  2011cited by this paper
• Transient exposure of neonatal mice to neuregulin-1 results in hyperdopaminergic states in adulthood: implication in neurodevelopmental hypothesis for schizophrenia

  2011cited by this paper
• Biodistribution and brain permeability of the extracellular domain of neuregulin-1-β1.

  2011cited by this paper
• Antipsychotic treatment and neuregulin 1-ErbB4 signalling in schizophrenia.

  2011cited by this paper
• Differential localization of neuregulin-1 type III in the central and peripheral nervous system.

  2011cited by this paper
• A Src link in schizophrenia

  2011cited by this paper
• Signaling pathways in schizophrenia: emerging targets and therapeutic strategies.

  2010cited by this paper
• Intramembranous Valine Linked to Schizophrenia Is Required for Neuregulin 1 Regulation of the Morphological Development of Cortical Neurons

  2010cited by this paper
• Gene expression of neuregulin-1 isoforms in different brain regions of elderly schizophrenia patients

  2010cited by this paper
• esearch report-methyl-d-aspartate ( NMDA ) receptor dysfunction or dysregulation : The final ommon pathway on the road to schizophrenia ?

  2010cited by this paper
• The role of histaminergic H1 and H3 receptors in food intake: a mechanism for atypical antipsychotic-induced weight gain?

  2010cited by this paper
• Cognition in transmembrane domain neuregulin 1 mutant mice.

  2010cited by this paper
• Control of cortical GABA circuitry development by Nrg1 and ErbB4 signalling

  2010cited by this paper
• ErbB3/HER3 intracellular domain is competent to bind ATP and catalyze autophosphorylation

  2010cited by this paper
• ErbB4 in parvalbumin-positive interneurons is critical for neuregulin 1 regulation of long-term potentiation

  2010cited by this paper
• A behavioural comparison of acute and chronic Delta9-tetrahydrocannabinol and cannabidiol in C57BL/6JArc mice.

  2010cited by this paper
• Decreased Neuregulin 1 C-terminal fragment in Brodmann's area 6 of patients with schizophrenia.

  2010cited by this paper
• A follow-up study: acute behavioural effects of Δ9-THC in female heterozygous Neuregulin 1 transmembrane domain mutant mice

  2010cited by this paper
• Measurement and comparison of serum neuregulin 1 immunoreactivity in control subjects and patients with schizophrenia: an influence of its genetic polymorphism

  2010cited by this paper
• Support for the involvement of the ERBB4 gene in schizophrenia: a genetic association analysis.

  2010cited by this paper
• A Phase II, randomized, double-blind, multicenter, based on standard therapy, placebo-controlled study of the efficacy and safety of recombinant human neuregulin-1 in patients with chronic heart failure.

  2010cited by this paper
• NRG1 and BDNF genes in schizophrenia: an association study in an Italian case-control sample.

  2010cited by this paper
• Phenotypic Characterization of Transgenic Mice Overexpressing Neuregulin-1

  2010cited by this paper
• Schizophrenia‐related endophenotypes in heterozygous neuregulin‐1 ‘knockout’ mice

  2010cited by this paper
• The neuregulin signaling pathway and schizophrenia: from genes to synapses and neural circuits.

  2010cited by this paper
• From receptor pharmacology to improved outcomes: individualising the selection, dosing, and switching of antipsychotics

  2010cited by this paper
• Biological validation of increased schizophrenia risk with NRG1, ERBB4, and AKT1 epistasis via functional neuroimaging in healthy controls.

  2010cited by this paper
• Neurodevelopmental mechanisms of schizophrenia: understanding disturbed postnatal brain maturation through neuregulin-1-ErbB4 and DISC1.

  2009cited by this paper
• In situ hybridization reveals developmental regulation of ErbB1-4 mRNA expression in mouse midbrain: implication of ErbB receptors for dopaminergic neurons.

  2009influential reference
• DTNBP1, NRG1, DAOA, DAO and GRM3 Polymorphisms and Schizophrenia: An Association Study

  2009cited by this paper
• Case–control study of association between the functional candidate gene ERBB3 and schizophrenia in Caucasian population*

  2009cited by this paper
• Selective populations of hippocampal interneurons express ErbB4 and their number and distribution is altered in ErbB4 knockout mice

  2009cited by this paper
• Mutant models for genes associated with schizophrenia.

  2009cited by this paper
• The neonatal ventral hippocampal lesion as a heuristic neurodevelopmental model of schizophrenia.

  2009cited by this paper
• Association study of NRG1, DTNBP1, RGS4, G72/G30, and PIP5K2A with schizophrenia and symptom severity in a Hungarian sample

  2009cited by this paper
• Delineation of additional PSD-95 binding domains within NMDA receptor NR2 subunits reveals differences between NR2A/PSD-95 and NR2B/PSD-95 association.

  2009cited by this paper
• Schizophrenia: A point of disruption

  2009cited by this paper
• Behavioural characterization of neuregulin 1 type I overexpressing transgenic mice

  2009cited by this paper
• Second-generation versus first-generation antipsychotic drugs for schizophrenia: a meta-analysis.

  2009cited by this paper
• Schizophrenia is not associated with the ERBB3 gene in a Han Chinese population sample: Results from case-control and family-based studies

  2009cited by this paper
• Neural circuitry models of schizophrenia: is it dopamine, GABA, glutamate, or something else?

  2009cited by this paper
• Selective Expression of ErbB4 in Interneurons, But Not Pyramidal Cells, of the Rodent Hippocampus

  2009cited by this paper
• Gene expression of NMDA receptor subunits in the cerebellum of elderly patients with schizophrenia

  2009cited by this paper
• Expression of ErbB4 in substantia nigra dopamine neurons of monkeys and humans.

  2009cited by this paper
• Impaired maturation of dendritic spines without disorganization of cortical cell layers in mice lacking NRG1/ErbB signaling in the central nervous system

  2009cited by this paper
• Neuregulin 1 hypomorphic mutant mice: enhanced baseline locomotor activity but normal psychotropic drug-induced hyperlocomotion and prepulse inhibition regulation.

  2009cited by this paper
• The neurodevelopmental hypothesis of schizophrenia, revisited.

  2009cited by this paper
• Upregulation of NRG-1 and VAMP-1 in human brain aggregates exposed to clozapine.

  2009cited by this paper
• ErbB4 Genotype Predicts Left Frontotemporal Structural Connectivity in Human Brain

  2009cited by this paper
• Neuregulin links dopaminergic and glutamatergic neurotransmission to control hippocampal synaptic plasticity

  2009cited by this paper
• Neuregulin 1 regulates pyramidal neuron activity via ErbB4 in parvalbumin-positive interneurons

  2009cited by this paper
• Chronic antipsychotic drug administration alters the expression of neuregulin 1beta, ErbB2, ErbB3, and ErbB4 in the rat prefrontal cortex and hippocampus.

  2008cited by this paper
• Evidence of missense mutations on the neuregulin 1 gene affecting function of prepulse inhibition.

  2008cited by this paper
• Association and interaction analyses of NRG1 and ERBB4 genes with schizophrenia in a Japanese population

  2008cited by this paper
• Type III Neuregulin-1 Is Required for Normal Sensorimotor Gating, Memory-Related Behaviors, and Corticostriatal Circuit Components

  2008cited by this paper
• Deficiency of Aph1B/C-γ-secretase disturbs Nrg1 cleavage and sensorimotor gating that can be reversed with antipsychotic treatment

  2008cited by this paper
• Neuregulin-1 regulates LTP at CA1 hippocampal synapses through activation of dopamine D4 receptors

  2008cited by this paper
• Behavioral profile of a heterozygous mutant mouse model for EGF-like domain neuregulin 1.

  2008cited by this paper
• Failure to replicate the association between NRG1 and schizophrenia using Japanese large sample.

  2008cited by this paper
• Disease-specific alterations in glutamatergic neurotransmission on inhibitory interneurons in the prefrontal cortex in schizophrenia.

  2008cited by this paper
• Alteration of BACE1-dependent NRG1/ErbB4 signaling and schizophrenia-like phenotypes in BACE1-null mice

  2008cited by this paper
• Elevated neuregulin-1 and ErbB4 protein in the prefrontal cortex of schizophrenic patients.

  2008cited by this paper
• ErbB4-Neuregulin Signaling Modulates Synapse Development and Dendritic Arborization through Distinct Mechanisms*

  2008cited by this paper
• Neuregulin 1 in neural development, synaptic plasticity and schizophrenia

  2008cited by this paper
• Explorative study on the expression of neuregulin-1 gene in peripheral blood of schizophrenia.

  2008cited by this paper
• Atypical antipsychotic drugs: current issues of safety and efficacy in the management of schizophrenia.

  2007cited by this paper
• Neuregulin1 (NRG1) Signaling through Fyn Modulates NMDA Receptor Phosphorylation: Differential Synaptic Function in NRG1+/− Knock-Outs Compared with Wild-Type Mice

  2007cited by this paper
• Immunohistochemical Evidence for Impaired Neuregulin‐1 Signaling in the Prefrontal Cortex in Schizophrenia and in Unipolar Depression

  2007cited by this paper
• Meltrin β (ADAM19) mediates ectodomain shedding of Neuregulin β1 in the Golgi apparatus: fluorescence correlation spectroscopic observation of the dynamics of ectodomain shedding in living cells

  2007cited by this paper
• Neuregulin-1 enhances depolarization-induced GABA release.

  2007cited by this paper
• Molecular Mechanisms of Schizophrenia

  2007cited by this paper
• Loss of erbB signaling in oligodendrocytes alters myelin and dopaminergic function, a potential mechanism for neuropsychiatric disorders

  2007cited by this paper
• Widespread expression of ErbB2, ErbB3 and ErbB4 in non-human primate brain.

  2007cited by this paper
• The EGF receptor family: spearheading a merger of signaling and therapeutics.

  2007cited by this paper
• Phenotypic characterization of spatial cognition and social behavior in mice with 'knockout' of the schizophrenia risk gene neuregulin 1.

  2007cited by this paper
• Postsynaptic density: a key convergent site for schizophrenia susceptibility factors and possible target for drug development.

  2007cited by this paper

• Elevated Neuregulin-1 in Severe COVID-19

  2026cites this paper
• Serum neuregulin -1 (NRG-1) is a potential biomarker for early diagnosis and prediction in refractory schizophrenia.

  2025cites this paper
• Differential Effects of Prenatal Poly I:C Exposure and Antipsychotics on NMDA/GABA Receptors and GSK3β‐Mediated Signaling in the Dorsal Raphe Nucleus of Female Rats

  2025cites this paper
• Regulation mechanisms of disulfidptosis-related genes in ankylosing spondylitis and inflammatory bowel disease

  2024cites this paper
• Exploring ncRNA-mediated regulation of EGFR signalling in glioblastoma: From mechanisms to therapeutics.

  2024cites this paper
• The Notch1/Hes1 pathway regulates Neuregulin 1/ErbB4 and participates in microglial activation in rats with VPA-induced autism.

  2024cites this paper
• Treadmill Running Regulates Adult Neurogenesis, Spatial and Non-spatial Learning, Parvalbumin Neuron Activity by ErbB4 Signaling

  2024cites this paper
• Peptide G-Protein-Coupled Receptors and ErbB Receptor Tyrosine Kinases in Cancer

  2023cites this paper
• Sarcosine May Induce EGF Production or Inhibit the Decline in EGF Concentrations in Patients with Chronic Schizophrenia (Results of the PULSAR Study)

  2023cites this paper
• Potential of olfactory neuroepithelial cells as a model to study schizophrenia: A focus on GPCRs (Review)

  2023cites this paper
• Long‐term effects of prophylactic MgSO4 in maternal immune activation rodent model at adolescence and adulthood

  2022cites this paper
• Uncovering the Underlying Mechanisms of Ketamine as a Novel Antidepressant

  2022cites this paper
• Effects of Risperidone and Prenatal Poly I:C Exposure on GABAA Receptors and AKT-GSK3β Pathway in the Ventral Tegmental Area of Female Juvenile Rats

  2022cites this paper
• Systems-Level Analysis of Genetic Variants Reveals Functional and Spatiotemporal Context in Treatment-resistant Schizophrenia

  2022cites this paper
• Overview of schizophrenia research and treatment in Pakistan

  2020cites this paper
• The role of ErbB4 in cancer

  2020cites this paper
• Genetic study of neuregulin 1 and receptor tyrosine-protein kinase erbB-4 in tardive dyskinesia

  2019cites this paper
• ISSN : 2469-5866 Neuregulin in Health and Disease

  2019cites this paper
• The ANKS1B gene and its associated phenotypes: focus on CNS drug response.

  2019cites this paper
• Neuregulin1 types mRNA level changes in autism spectrum disorder, and is associated with deficit in executive functions

  2018cites this paper
• Neuregulin in Health and Disease.

  2018cites this paper
• Neuregulin 1 (NRG1) gene expression predicts functional outcomes in individuals at clinical high-risk for psychosis.

  2018cites this paper
• Schizophrenia and neurogenesis: A stem cell approach.

  2017cites this paper
• Genetic association analysis of ERBB4 polymorphisms with the risk ofschizophrenia susceptibility in a Jordanian population of Arab descent.

  2017cites this paper
• Association between ErbB4 single nucleotide polymorphisms and susceptibility to schizophrenia

  2017cites this paper
• Disrupted hippocampal neuregulin-1/ErbB3 signaling and dentate gyrus granule cell alterations in suicide

  2017cites this paper
• Functional dissection of astrocyte-secreted proteins: Implications in brain health and diseases.

  2017cites this paper
• Contribution of NRG1 Gene Polymorphisms in Temporal Lobe Epilepsy

  2016cites this paper
• Dysregulation of Neuregulin-1/ErbB signaling in the prefrontal cortex and hippocampus of rats exposed to chronic unpredictable mild stress.

  2016cites this paper
• Fingerprinting of neurotoxic compounds using a mouse embryonic stem cell dual luminescence reporter assay

  2016cites this paper
• Neuregulin-1 and schizophrenia in the genome-wide association study era.

  2016cites this paper
• Antipsychotics promote neural differentiation of human iPS cell-derived neural stem cells.

  2016cites this paper
• A systematic review comparing sex differences in cognitive function in schizophrenia and in rodent models for schizophrenia, implications for improved therapeutic strategies.

  2016cites this paper
• Chronic stress and excessive glucocorticoid exposure both lead to altered Neuregulin-1/ErbB signaling in rat myocardium.

  2016cites this paper
• Selected PET Radioligands for Ion Channel Linked Neuroreceptor Imaging: Focus on GABA, NMDA and nACh Receptors.

  2016cites this paper
• Effects of prolonged antipsychotic administration on neuregulin-1/ErbB signaling in rat prefrontal cortex and myocardium: implications for the therapeutic action and cardiac adverse effect.

  2016cites this paper
• Genetic association between NRG1 and schizophrenia, major depressive disorder, bipolar disorder in Han Chinese population

  2016influential citation
• Modeling Gene–Environment Interaction in Schizophrenia

  2016cites this paper
• Impairment of Oligodendroglia Maturation Leads to Aberrantly Increased Cortical Glutamate and Anxiety-Like Behaviors in Juvenile Mice

  2015cites this paper
• Neuregulin 1 Attenuates Neuronal Apoptosis Induced by Deep Hypothermic Circulatory Arrest Through ErbB4 Signaling in Rats

  2015cites this paper
• Modulation of schizophrenia-related genes in the forebrain of adolescent and adult rats exposed to maternal immune activation.

  2015cites this paper
• Effects of genetic variations in NRG1 on cognitive domains in patients with schizophrenia and healthy individuals

  2015cites this paper
• Expression quantitative trait loci (eQTLs) in microRNA genes are enriched for schizophrenia and bipolar disorder association signals

  2015cites this paper
• Functional mechanisms for type 2 diabetes-associated genetic variants.

  2015cites this paper
• Evaluation of genetic association of neurodevelopment and neuroimmunological genes with antipsychotic treatment response in schizophrenia in Indian populations

  2015cites this paper
• Neuregulin 1 Prevents Phencyclidine-Induced Behavioral Impairments and Disruptions to GABAergic Signaling in Mice

  2015cites this paper
• Large-scale candidate gene study to identify genetic risk factors predictive of paliperidone treatment response in patients with schizophrenia

  2015cites this paper
• Differential effects of short- and long-term antipsychotic treatment on the expression of neuregulin-1 and ErbB4 receptors in the rat brain.

  2015influential citation
• Drugs targeting SNPrs35753505 of the NRG1 gene may prevent the association of neurological disorder schizophrenia in a Pakistani population.

  2014cites this paper
• The Glutamatergic Aspects of Schizophrenia Molecular Pathophysiology: Role of the Postsynaptic Density, and Implications for Treatment

  2014cites this paper
• Gene expression changes consistent with neuroAIDS and impaired working memory in HIV-1 transgenic rats

  2014cites this paper
• The effect of Neuregulin 1 on PCP induced alterations of locomotion, neurotransmission and cell growth as relevant for schizophrenia

  2014cites this paper
• Neuregulin-1 alpha, the underestimated molecule: emerging new roles in normal brain function and the pathophysiology of schizophrenia?

  2013cites this paper
• Perspectives of a Systems Biology of the Brain: The Big Data Conundrum Understanding Psychiatric Diseases

  2013cites this paper